Healthcare DIVE August 2, 2024
The deal with private equity firms TowerBrook and CD&R comes months after New Mountain Capital announced its own takeover bid, which some analysts thought undervalued the company.
Dive Brief:
- Private equity firms TowerBrook Capital Partners and Clayton, Dubilier and Rice entered into a definitive agreement to acquire R1 RCM for about $8.9 billion and take the company private, the revenue cycle management firm said Thursday.
- TowerBrook currently controls around 36% of the company’s shares, according to a press release. Under the deal, which will take R1 private, TowerBrook and CD&R will buy the rest of the company’s outstanding stock for $14.30 per share.
- The acquisition comes months after another private equity firm, New Mountain Capital, offered to buy...